FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/03/050162 [Registered on: 01/03/2023] Trial Registered Prospectively
Last Modified On: 28/02/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Preventive 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Comparing two doses of Pregabalin for prevention of fasciculations and myalgia caused by Succinylcholine 
Scientific Title of Study   Comparison of two doses of Pregabalin for preventing Succinylcholine-induced fasciculations and myalgia in patients undergoing surgery under General Anaesthesia: A Randomized controlled study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Malavika Sasidharan 
Designation  Junior Resident in Anaesthesiology  
Affiliation  Shri B M Patil Medical College, Vijayapura  
Address  Department of Anaesthesiology,Shri B M Patil Medical College, Bangaramma Sajjan Campus,Vijayapura

Bijapur
KARNATAKA
586103
India 
Phone  7034085160  
Fax    
Email  malavikas040@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Renuka Holyachi  
Designation  Professor 
Affiliation  Shri B M Patil Medical College, Vijayapura  
Address  Department of Anaesthesiology,Shri B M Patil Medical College,Bangaramma Sajjan Campus,Vijayapura

Bijapur
KARNATAKA
586103
India 
Phone  9886492178  
Fax    
Email  renuka312@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Malavika Sasidharan  
Designation  Junior Resident in Anaesthesiology  
Affiliation  Shri B M Patil Medical College, Vijayapura  
Address  Department of Anaesthesiology,Shri B M Patil Medical College, Bangaramma Sajjan Campus,Vijayapura

Bijapur
KARNATAKA
586103
India 
Phone  7034085160  
Fax    
Email  malavikas040@gmail.com  
 
Source of Monetary or Material Support  
Shri B M Patil Medical College,Bangaramma Sajjan Campus,BLDE University,Vijayapura,Karnataka,Pin 586103 
 
Primary Sponsor  
Name  Shri B M Patil Medical College  
Address  Bangaramma Sajjan Campus,BLDE University,Vijayapura,Karnataka,Pin 586103 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Malavika Sasidharan   Shri B M Patil Medical College   Department of Anaesthesiology, Bangaramma Sajjan Campus,BLDE University,Vijayapura,
Bijapur
KARNATAKA 
7034085160

malavikas040@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Shri B M Patil Medical College   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Capsule PREGABALIN   A drug used for Neuropathic pain,fibromyalgia,convulsions,etc, Route:Oral Capsule, Dosage:either 75mg or 150mg, Frequency:Single dose 2 hours prior to surgery 
Comparator Agent  Saccharin pill  Sucrose sugar sweetner pills used as placebo, Route:Oral Tablet, Dosage:49.2mg, Frequency:single dose 2 hours prior to surgery 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients undergoing surgery under General Anaesthesia.
ASA grade 1 or 2
 
 
ExclusionCriteria 
Details  Patients with drug allergies
Seizure history
Cardiac diseases
Impaired kidney or Liver function
Raised intracranial pressure or intraocular pressure
Patients on Antiepileptics,antidepressants,calcium channel blockers
Pregnant and Lactating Females
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the efficacy of two doses of Pregabalin in preventing Succinylcholine-Induced fasciculations and myalgia  2 hours 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the hemodynamic stability and 24 hour post operative analgesic requirement of the patients who received Pregabalin and the patients who received only Placebo  24 hours 
 
Target Sample Size   Total Sample Size="201"
Sample Size from India="201" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/03/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="30" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a Prospective Randomized,Parallel group,double blinded study.This study consists of 3 groups where Group A who will receive Capsule Pregabalin 75mg,Group B will receive Capsule Pregabalin 150mg and Group C will receive Saccharin pill as Placebo.201 patients posted for surgery under General Anaesthesia will be equally divided into these three groups as 67 each.The study will be conducted in Shri B M Patil Medical College,Vijayapura,Karnataka.The primary outcome is to compare the efficacy of two doses of Pregabalin in preventing Succinylcholine induced fasciculations and myalgia in patients undergoing surgery under General Anaesthesia.The secondary outcome is to compare the hemodynamic stability and 24 hour post operative analgesic requirement of the patients who received Pregabalin and the patients who received only Placebo. 
Close